Skip to main content

Precision Medicine

By Nathan Eddy | 01:00 am | July 19, 2019
Garvan Institute of Medical Research scientists hope the method, called RAGE-seq, could have powerful applications for precision medicine.
Innovation
By Nathan Eddy | 11:54 am | July 17, 2019
Researchers are working with digital therapeutics specialist Biofourmis, using machine learning technology and the Apple Watch to analyze dozens of physiology biomarkers.
Workforce Development
By Nathan Eddy | 11:54 am | July 15, 2019
The 10-year initiative will focus on workforce development, education and training for next-generation care delivery.
By Mike Miliard | 12:28 pm | July 11, 2019
A multi-year agreement with the machine learning company will start with a tool to identify high-risk GI patients, eventially expanding to other high-burden diseases.
By HIMSS TV | 12:40 pm | July 10, 2019
Nearly 20% of Estonia's citizens are gene donors, which is useful when it comes to implementing precision medicine, says Kalle Killar, deputy secretary general at the Ministry of Social Affairs.
By Nathan Eddy | 04:21 pm | June 27, 2019
Pre-treatment scans were input into a deep-learning model, which analyzed the scans to create an image signature that predicts treatment outcomes.
By Nathan Eddy | 01:00 am | June 25, 2019
The device, which can be used on whole blood samples regularly taken at pathology labs, could one day help doctors diagnose cancer at its earliest stages.
By Mike Miliard | 04:33 pm | June 20, 2019
The pioneering Pennsylvania health system has picked Ryu, who most recently served as its chief medical officer, to replace Dr. David Feinberg, who joined Google in 2018.
By Benjamin Harris | 12:20 pm | June 14, 2019
The largest U.S.-based genetics study – 500,000 samples drawn from Intermountain Health’s patient population – aims to improve precision medicine.
By Google Cloud | 08:07 am | June 14, 2019
The real challenge in precision medicine is achieving precision in analytics and experiments to get very specific results for very specific people, says William Moss, CEO, Seven Bridges Genomics Inc.